Ottawa, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The global radiotherapy market size is expected to surpass USD 14.76 billion by 2034, increasing from USD 9.10 billion in 2026, growing at a strong CAGR of 6.25% between 2025 and 2034. Rising healthcare infrastructure, R&D investments, and growing public awareness related to cancer therapy are driving the growth of the market.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/4421
Radiotherapy Market Highlights:
- North America accounted for the largest market share of 37% in 2024.
- Asia Pacific is expected to expand at a notable CAGR from 2025 to 2034.
- By type, the external beam radiation therapy segment contributed the highest market share in 2024.
- By type, the internal radiation therapy segment is growing at a strong between 2025 and 2034.
- By end users, the hospitals & clinics segment held more than 51% of market share in 2024.
- By end users, the other segment is growing at the fastest CAGR from 2025 to 2034.
What is Radiotherapy?
The radiotherapy market refers to the production, distribution, and use of radiotherapy, which is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. At low doses, radiation is used in X-rays to see inside our bodies, such as with X-rays of our teeth or broken bones. Radiotherapy benefits include its use in diagnosing illness, and in high doses, to treat diseases like cancer. High doses of radiation are used to kill harmful bacteria in food and to extend the shelf life of fresh produce. Radiation produces heat that is used to generate electricity in nuclear power reactors.
Radiotherapy treats cancer effectively. It reduces recurrence risks, relieves symptoms, and improves outcomes. When it is used to treat cancer, radiation therapy can cure cancer, prevent it from returning, or stop or slow its growth. It is a protected and successful therapy for some kinds of cancer.
➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting
Major Applications of Radiotherapy:
1. Curative cancer treatment - Radiotherapy is used as a primary or sole treatment to cure certain localized cancers, especially in early stages. It works by using high-energy radiation to damage the DNA of cancer cells, preventing them from growing and dividing.
2. Palliative care - For patients with advanced or incurable cancer, radiotherapy can be used for palliative care to relieve symptoms and improve their quality of life. It helps manage symptoms like pain from bone metastases, bleeding from tumors, and pressure on vital organs, such as the spinal cord or airways.
3. Neoadjuvant and adjuvant therapy - Radiotherapy can be used alongside other treatments like surgery and chemotherapy to improve outcomes. It is used as neoadjuvant therapy before surgery to shrink a tumor and make it easier to remove, or as adjuvant therapy after surgery to kill any remaining cancer cells and reduce the risk of recurrence.
4. Treatment of benign conditions - Radiotherapy can also be used to treat certain non-cancerous diseases, such as aggressive fibromatosis (desmoid tumors), keloid scars, and some benign brain tumors. For these conditions, low doses of radiation are often used to inhibit the growth of abnormal cells or to reduce inflammation.
5. Combination with other therapies - Radiotherapy is frequently combined with other cancer treatments to enhance their effectiveness. For instance, it can work synergistically with immunotherapy to improve the body's immune response against tumors or be used concurrently with chemotherapy to increase tumor sensitivity to radiation.
✚ Turn AI disruption into Opportunity. Click to Get the Insights Shaping Tomorrow.
What are Key Trends of the Radiotherapy Market?
- Shift toward precision and personalization: Radiotherapy is moving away from a one-size-fits-all approach by increasingly using advanced imaging and molecular data to tailor treatment plans to individual patients. This allows for more targeted radiation delivery, maximizing the dose to tumors while minimizing exposure and side effects in surrounding healthy tissues.
- Integration of artificial intelligence (AI): Artificial intelligence is being integrated across the radiotherapy workflow to improve precision and efficiency. AI-powered software helps automate time-consuming tasks like contouring and planning, and enables real-time adjustments for adaptive therapy.
- Expansion of particle therapy: Particle therapies, particularly proton therapy, are expanding due to their superior dose distribution, which delivers highly targeted radiation to the tumor with less radiation to surrounding healthy tissue. The market is also seeing the development of more compact, single-room proton systems to make the therapy more accessible and affordable.
- Adoption of hypofractionation: This trend involves delivering higher doses of radiation in fewer treatment sessions, which improves efficiency and patient convenience. Growing clinical evidence confirms that these shorter regimens are as effective for many cancers, reducing the burden on both patients and healthcare resources.
- Growth of adaptive and image-guided radiation therapy (ART/IGRT): Advanced imaging technology, including magnetic resonance imaging (MRI) and PET, is being integrated into treatment systems to visualize tumors and patient anatomy in real-time. This allows for online adaptive therapy, where treatment plans can be modified daily to account for changes in tumor size or patient position, ensuring the most accurate dose delivery.
➤ Get the Full Report @ https://www.precedenceresearch.com/radiotherapy-market
Radiotherapy Market Opportunity
Technological Advancements
Technological advancements present growth opportunities for the radiotherapy market. Developments such as AI-based delineation and treatment planning improve data quality and outcome modeling for adaptive radiotherapy.
Digital radiotherapy benefits include the capability for remote viewing from connected digital devices, images that are easier to store and share with doctors, faster processing & diagnosis, extremely high image quality, enhanced detail detectability, and shorter exposure times.
Radiotherapy Market Challenges
Lack of Skilled Professionals
Lack of skilled professionals can limit the growth of the market. The global shortages of skilled radiation therapy professionals pose significant barriers to oART implementation. They may result in the loss of valuable institutional knowledge, training, creating additional costs in recruitment, and higher turnover rates. The absence of skilled workers may lead to an increase in workplace accidents and injuries. A shortage of skilled labor may hinder the innovation.
Radiotherapy Market Report Scope
| Report Attribute | Details |
| Market Size in 2025 | USD 8.56 Billion |
| Market Size in 2026 | USD 9.10 Billion |
| Market Size by 2034 | USD 14.76 Billion |
| Market Growth Rate (2025–2034) | CAGR of 6.25% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Leading Region in 2024 | North America |
| Segments Covered | Type, End-user, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Key Segment Insights (2024) | • External Beam Radiation Therapy held the major share. • Hospitals & Clinics accounted for more than 51% of revenue. |
| Segment Growth Outlook | • Internal Radiation Therapy expected to grow notably. • Outpatient and specialized cancer centers to show strong expansion. |
| Key Market Drivers | • Increasing global cancer incidence. • Rising adoption of advanced radiotherapy equipment and precision treatment technologies. |
| Market Challenges | • Shortage of skilled radiology and oncology professionals. |
| Growth Opportunities | • Improved linear accelerators and image-guided radiotherapy systems driving adoption. • Expansion of cancer care centers and rising access in emerging markets. |
| Market Landscape | • Highly fragmented market with both global and regional radiotherapy equipment manufacturers. |
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/4421
Case Study: How Advanced Radiotherapy Transformed Cancer Care in a Leading Oncology Hospital
Client Overview
A multi-specialty oncology hospital in North America, treating over 45,000+ cancer patients annually, wanted to improve treatment accuracy, reduce side effects, and enhance patient outcomes across breast, lung, and prostate cancer cases.
Key Challenges
The hospital faced several limitations with its traditional radiotherapy infrastructure:
- High treatment times leading to long waiting lists
- Limited precision with older linear accelerators
- Inconsistent treatment outcomes for complex tumors
- Increasing demand due to rising cancer incidence
- Lack of AI-enabled planning tools, causing delays in treatment planning
The leadership wanted to modernize its radiotherapy department with next-generation technology.
Solution Implemented
The hospital partnered with a global radiotherapy equipment manufacturer to deploy a comprehensive radiotherapy upgrade, including:
1. Installation of Advanced Linear Accelerators (LINACs)
- Equipped with image-guided radiotherapy (IGRT)
- Enabled intensity-modulated radiotherapy (IMRT)
- Reduced setup and treatment time by 33%
2. Integration of AI-Based Treatment Planning
- Automated tumor contouring
- Personalized radiation dose delivery
- Reduced planning time from 3 hours to 20 minutes
3. Adoption of Stereotactic Body Radiotherapy (SBRT)
- Enabled ultra-precise targeting of small, complex tumors
- Allowed treatments in 1–5 sessions instead of 20–30
4. Workforce Upskilling
- Radiation oncologists and therapists trained on the new system
- Real-time quality assurance software minimized human error
Outcomes Achieved (Within 12 Months)
| KPI | Before | After | Impact | ||
| Treatment Accuracy | 82% | 96% | +14% improvement | ||
| Average Treatment Time | 20–25 min | 10–12 min | 50% faster | ||
| Patient Throughput | 65/day | 110/day | +69% capacity increase | ||
| Waiting Time for Therapy | 12 days | 3 days | 75% reduction | ||
| Re-treatment / Corrections | High | Very Low | Improved quality | ||
| Patient Satisfaction | Moderate | Excellent | Better care experience | ||
Clinical Impact
Better Outcomes for Breast and Lung Cancer Patients
- Reduced radiation exposure to surrounding organs
- Higher tumor control rates
- Fewer side effects and faster recovery
Improved Survival & Quality of Life
Patients reported fewer complications and quicker return to daily life.
Enhanced Reputation
The hospital became a regional leader in precision radiotherapy, attracting referrals from multiple states.
Business Impact
Revenue Growth
- New radiotherapy capabilities increased hospital revenue by 32% YoY
- SBRT and IGRT services attracted high-value patients
Operational Efficiency
- Higher throughput reduced per-patient cost
- Upgraded workflow reduced overtime and staffing pressure
Competitive Advantage
The hospital positioned itself as one of the top three advanced radiotherapy centers in its region.
Key Takeaways
- Technology upgrades (LINAC, IGRT, SBRT, AI planning) significantly improve clinical outcomes.
- Hospitals using precision radiotherapy experience higher patient satisfaction and operational efficiency.
- Investment in modern radiotherapy offers long-term ROI and strong competitive differentiation.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Radiotherapy Market Regional Insights
North America Radiotherapy Market
North America held the largest share of the market in 2024 due to a shift towards non-surgical options, increased healthcare spending, expanding access to care, rising awareness & demand, technological advancements, and rising cancer rates in the region. In the United States, radiation oncology residency programs follow a preliminary year.
According to the Bureau of Labor Statistics, there are 16640 radiation therapists in the U.S. North America saw increased rates of cancer and technological advancements, with external-beam radiation therapy. Key technological advancements like RefleXion Medical’s clinical study for biology-guided radiotherapy and the acquisition of Oncospace by Sun Nuclear to leverage AI solutions contribute to the market growth.
How Big is the U.S. Radiotherapy Market?
According to Precedence Research, the U.S. radiotherapy market size is valued at USD 2.38 billion in 2025 and is projected to reach nearly USD 4.19 billion by 2034, expanding at a solid CAGR of 6.51% from 2025 to 2034.
Robust Innovation Ecosystem: Boost the U.S. Market
The U.S. dominates the regional market, due to its benefits from a strong innovation ecosystem that accelerates the development and adoption of cutting-edge radiotherapy technologies. Major medical device companies, research institutions, and cancer centers based in the U.S. are continuously involved in clinical trials and product development, leading to the early commercialization and integration of next-generation radiotherapy systems.
The regulatory environment, particularly the FDA's framework for medical devices, further facilitates timely approval and market entry of novel treatments.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/4421
Asia Pacific Radiotherapy Market
Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period because of the cloud-based solutions, increased awareness, specialized care, emerging economies, cost reduction & infrastructure, and technological advancements in the region. Most of the hospitals for radiation therapy in India are ISO, NABH, NABL, and CAP-accredited and recognized by DSIR.
With the growing prevalence of cancer and increasing healthcare expenditure, with government initiatives and support, the adoption of radiotherapy has increased in Asia. The growing focus on technological advancements and preference for ambulatory care centers are fueling this growth.
Two-Dimensional Radiotherapy: Rapid Trend in the China
China dominates the regional market, due to its rapid shift from basic two-dimensional radiotherapy to more advanced modalities such as Intensity-Modulated Radiotherapy (IMRT), Image-Guided Radiotherapy (IGRT), and Stereotactic Body Radiotherapy (SBRT), driven by both government support and rising demand for higher-quality cancer care.
Favorable reimbursement reforms and broader health insurance coverage are also helping to reduce the out-of-pocket burden on patients, encouraging more widespread utilization of radiotherapy. Compared to other nations in the Asia Pacific, such as India, Japan, and Australia, China's combination of high patient volume, expanding healthcare infrastructure, growing technological adoption, and state-led investment gives it a substantial edge in the regional radiotherapy market.
Radiotherapy Market Segmentation Insights:
Type Insights
Which Type Dominates the Radiotherapy Market?
External beam radiation therapy (EBRT) dominated the market in 2024. It uses high-energy beams to kill cancer cells, reaching deep into the body and affecting both cancerous and healthy cells. Each EBRT session typically lasts about 10 to 30 minutes, with most time spent on patient positioning.
- In January 2025, the initiation of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX® biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer Center, a research partner with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center, was announced by Reflexion Medical, an external-beam theragnostic oncology company.
The internal radiation therapy segment is expected to gain a significant market share from 2025 to 2034. It delivers large amounts of radiation directly to tumors, sparing healthy tissue and reducing hospital visits with shorter treatment durations and higher precision in targeting cancer cells.
- In August 2025, two new radiation therapy devices, the Halcyon Hypersight and TrueBeam linear accelerators, were introduced by Konkuk University Medical Center. TrueBeam is a radiation therapy device that can treat cancer without surgery. The imaging radiation dose improves the contrast resolution is improved and reduced by half, enabling accurate targeting of tumors.
End-user Insights
What Made the Hospitals & Clinics Lead the Radiotherapy Market?
The hospitals & clinics segment led the market during 2024. Radiation therapy is used to treat cancer and ease cancer symptoms. Radiation therapy is used in hospitals for cancer treatment. This treatment uses beams of intense energy to kill cancer cells. Radiation therapy mostly uses X-rays. The benefits of hospitals & clinics include reduced waiting times, comprehensive medical care, cost savings, quality of care, convenience, and accessibility. Hospital management systems digitize and centralize operations, improving efficiency and patient care.
- In June 2025, the development of a specialized cancer block at the Homi Bhabha Cancer Hospitals and Research Centre (HBCHRC) in Visakhapatnam was announced by ICICI Bank, in collaboration with Tata Memorial Center (TMC). This initiative was driven by the ICICI Foundation for Inclusive Growth, focuses on hematolymphoid and pediatric cancers and is poised to become one of the most innovative cancer care facilities in eastern India.
The specialty cancer centers segment is predicted to witness significant growth in the market over the forecast period. The purpose of specialty cancer centers includes screening & prevention, research, diagnosis, treatment, rehabilitation, social/emotional support, and survivorship programs. Additionally, cancer centers provide many psychological support services to help patients and their loved ones deal with the disease and its treatment. NCI-designated cancer centers meet standards for cancer prevention, clinical services, or research as determined by the NCI.
- In August 2025, Siddipet’s first super specialty cancer center, offering comprehensive cancer treatment locally to patients who previously had to travel to Hyderabad for advanced care, was CION Cancer Clinics. This new facility is a part of CION’s expanding distributed care model and is staffed by a team of over 15 oncologists across radiation, medical, and surgical specialties. It delivers a full range of services, including nutrition counselling, psycho-oncology, genetic testing, molecular diagnostics, bone marrow transplants, cancer surgery, radiation therapy, immunotherapy, and chemotherapy.
✚ Related Topics You May Find Useful:
➡️ Radiopharmaceuticals Market: Explore how targeted nuclear medicines are transforming diagnostic imaging and cancer therapy
➡️ Medical Radiation Detection Market: Understand how safety monitoring technologies are advancing radiation protection in clinical environments
➡️ Medical Radiation Shielding Market: Learn how rising diagnostic imaging procedures are driving demand for protective infrastructure
➡️ U.S. Radiopharmaceutical Therapies Market: Track the rapid adoption of targeted radionuclide therapies across oncology centers
➡️ Cancer Therapeutics Market: Discover emerging drugs, immunotherapies, and precision treatments reshaping cancer care
➡️ Radiation Protection Market: See how healthcare digitization and imaging expansion are boosting protective equipment demand
➡️ Oncology Information System Market: Analyze how digital oncology platforms are enhancing treatment planning and patient outcomes
➡️ Brachytherapy Market: Explore why minimally invasive internal radiation therapies are gaining global traction
➡️ Cancer Diagnostics Market: Understand how early detection technologies and AI-driven tools are transforming oncology diagnosis
➡️ Breast Cancer Market: Gain insight into evolving treatment pipelines, screening programs, and rising therapy adoption
Radiotherapy Market Top Companies
- Nordion Inc.: A leading supplier of medical-grade Cobalt-60 sources, which are used for radiation therapy, including stereotactic radiosurgery.
- Accuray Incorporated: Develops and manufactures radiation therapy systems like the CyberKnife and TomoTherapy platforms for treatments such as stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
- iCAD Inc.: Offers the Xoft Axxent Electronic Brachytherapy (eBx) System, a non-invasive technology that delivers low-energy radiation for targeted cancer treatment.
- Siemens Healthineers AG: Provides medical imaging systems, including CT and MRI scanners, and software solutions for radiation therapy planning and delivery. The company also acquired Varian Medical Systems.
- Isoray, Inc. (now Perspective Therapeutics, Inc.): Specializes in internal radiation therapy using Cesium-131 brachytherapy seeds, which are small radioactive implants used to treat certain cancers.
- MEVION MEDICAL SYSTEMS, INC.: Manufactures and sells compact proton therapy systems, which use proton beams for more targeted cancer treatment, reducing radiation exposure to surrounding healthy tissue.
- Becton, Dickinson, and Company: A medical technology company that primarily provides surgical supplies, diagnostics, and devices for medication delivery, with no major offering in the core field of radiotherapy equipment.
- Ion Beam Applications SA: A global leader in proton therapy, providing a range of systems from full-scale centers to single-room solutions, as well as dosimetry and particle accelerators.
- Elekta AB: A Swedish company that develops and manufactures linear accelerators, brachytherapy solutions, and radiosurgery equipment for treating cancer and brain disorders.
- Eckert & Ziegler Group: A provider of isotope technology for medical applications, including brachytherapy seeds and accessories for radiation therapy.
- Varian Medical Systems: A major developer of linear accelerators, software for cancer clinics, proton therapy systems, and adaptive therapy solutions (now part of Siemens Healthineers).
- RefleXion: Developed SCINTIX Biology-Guided Radiotherapy (BgRT), which uses signals from cancer cells to track and guide the delivery of radiation in real time.
- NTP Isotopes: A global supplier of medical radioisotopes and related nuclear products used in nuclear medicine, including radiopharmaceutical therapy.
- Mitsubishi Electric: Offers particle therapy systems, including proton and carbon-ion therapy equipment, as well as a multi-function irradiation nozzle for enhanced beam delivery.
Recent Developments
- In October 2025, the launch of the High-Dose-Rate (HDR) Brachytherapy Unit was announced by ShardaCare Healthcity. This technology goal to deliver patient-centric, precision-driven cancer care through cutting-edge innovation.
- In September 2025, the All-in-One radiotherapy solution with advanced capabilities designed to set a new standard in cancer care, the introduction of the Accuracy Stellar Solution was announced by Accuracy Incorporated.
- In April 2025, a new stem cell research project to improve healing for patients suffering from severe radiation skin injuries was launched by the IAEA. For patients suffering from radiation damage to their skin, the path to healing may be painful and long. This new coordinated research project (CRP) explores the use of specific types of stem cells in developing regenerative therapies for severe radiation-injured skin injuries.
Segments Covered in the Report
By Type
- External Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiation Therapy
By End-user
- Hospitals and Clinics
- Specialty Cancer Centers
- Others
By Region
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/4421
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344
Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor | Market Stats Insight | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
Get Recent News:
https://www.precedenceresearch.com/news
For the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter
✚ Explore More Market Intelligence from Precedence Research:
➡️ Digital Therapeutics: How software-based interventions are restructuring chronic-disease management and clinical-grade behavioral therapy
➡️ Life Sciences Growth: Forces driving expansion across biotech, biopharma, and advanced therapeutic platforms
➡️ Viral Vector Gene Therapy Manufacturing: Manufacturing constraints, scalability limits, and innovations shaping next-generation gene-delivery systems
➡️ Wellness Transformation: How prevention-centric health models are shifting consumer behavior, product pipelines, and care delivery
➡️ Generative AI in Healthcare: How generative models are unlocking new diagnostics, clinical automation, and patient-care innovations
